Hält derzeit eine Position bei AVROBIO Inc
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | AVROBIO Inc | 1. Februar 2016 - |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-15 | 2024-03-15 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
10.411
-1.3%
40,62422.895 USD |
10.411 -1.3% | 40,62 | 422.895 USD | |
2024-03-15 | 2024-03-14 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
7.292
-0.9%
39,73289.711 USD |
7.292 -0.9% | 39,73 | 289.711 USD | |
2024-03-15 | 2024-03-14 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
781
-0.0%
41,5132.419 USD |
781 -0.0% | 41,51 | 32.419 USD | |
2024-03-15 | 2024-03-14 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
10.846
-0.2%
40,66440.998 USD |
10.846 -0.2% | 40,66 | 440.998 USD | |
2024-03-15 | 2024-03-14 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
34.473
-0.7%
39,731.369.612 USD |
34.473 -0.7% | 39,73 | 1.369.612 USD | |
2024-03-13 | 2024-03-13 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
1.386
-0.2%
42,8459.376 USD |
1.386 -0.2% | 42,84 | 59.376 USD | |
2024-03-13 | 2024-03-13 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
22.779
-2.7%
42,19961.046 USD |
22.779 -2.7% | 42,19 | 961.046 USD | |
2024-03-13 | 2024-03-13 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
6.686
-0.1%
42,84286.428 USD |
6.686 -0.1% | 42,84 | 286.428 USD | |
2024-03-13 | 2024-03-13 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
108.404
-2.3%
42,194.573.565 USD |
108.404 -2.3% | 42,19 | 4.573.565 USD | |
2024-03-13 | 2024-03-12 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
1.819
-0.2%
42,5277.344 USD |
1.819 -0.2% | 42,52 | 77.344 USD | |
2024-03-13 | 2024-03-12 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
26.452
-3.0%
41,941.109.397 USD |
26.452 -3.0% | 41,94 | 1.109.397 USD | |
2024-03-13 | 2024-03-12 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
8.581
-0.2%
42,52364.864 USD |
8.581 -0.2% | 42,52 | 364.864 USD | |
2024-03-13 | 2024-03-12 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
126.066
-2.6%
41,945.287.208 USD |
126.066 -2.6% | 41,94 | 5.287.208 USD | |
2024-03-13 | 2024-03-11 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
1.045
-0.1%
43,4245.374 USD |
1.045 -0.1% | 43,42 | 45.374 USD | |
2024-03-13 | 2024-03-11 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
7.837
-0.9%
42,77335.188 USD |
7.837 -0.9% | 42,77 | 335.188 USD | |
2024-03-13 | 2024-03-11 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
5.122
-0.1%
43,42222.397 USD |
5.122 -0.1% | 43,42 | 222.397 USD | |
2024-03-13 | 2024-03-11 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
37.180
-0.7%
42,771.590.189 USD |
37.180 -0.7% | 42,77 | 1.590.189 USD | |
2023-01-13 | 2023-01-12 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
21.592
-2.4%
30,29654.022 USD |
21.592 -2.4% | 30,29 | 654.022 USD | |
2023-01-13 | 2023-01-12 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
77.128
-1.5%
30,292.336.207 USD |
77.128 -1.5% | 30,29 | 2.336.207 USD | |
2023-01-13 | 2023-01-11 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
6.071
-0.7%
29,96181.887 USD |
6.071 -0.7% | 29,96 | 181.887 USD | |
2023-01-13 | 2023-01-11 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
21.683
-0.4%
29,96649.623 USD |
21.683 -0.4% | 29,96 | 649.623 USD | |
2022-12-16 | 2022-12-15 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
717
-0.1%
30,0021.510 USD |
717 -0.1% | 30,00 | 21.510 USD | |
2022-12-16 | 2022-12-15 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
2.561
-0.1%
30,0076.830 USD |
2.561 -0.1% | 30,00 | 76.830 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
3.733
-0.4%
34,02126.997 USD |
3.733 -0.4% | 34,02 | 126.997 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
3.919
-0.4%
33,34130.659 USD |
3.919 -0.4% | 33,34 | 130.659 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
15.324
-1.6%
32,33495.425 USD |
15.324 -1.6% | 32,33 | 495.425 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
28.329
-2.9%
31,44890.664 USD |
28.329 -2.9% | 31,44 | 890.664 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
31.584
-3.2%
30,28956.364 USD |
31.584 -3.2% | 30,28 | 956.364 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
13.335
-0.3%
34,02453.657 USD |
13.335 -0.3% | 34,02 | 453.657 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
13.997
-0.3%
33,34466.660 USD |
13.997 -0.3% | 33,34 | 466.660 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
54.737
-1.1%
32,331.769.647 USD |
54.737 -1.1% | 32,33 | 1.769.647 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
101.189
-1.9%
31,443.181.382 USD |
101.189 -1.9% | 31,44 | 3.181.382 USD | |
2022-12-16 | 2022-12-14 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
112.819
-2.1%
30,283.416.159 USD |
112.819 -2.1% | 30,28 | 3.416.159 USD | |
2022-11-04 | 2022-11-03 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
21.085
-2.1%
30,00632.550 USD |
21.085 -2.1% | 30,00 | 632.550 USD | |
2022-11-04 | 2022-11-03 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
75.312
-1.4%
30,002.259.360 USD |
75.312 -1.4% | 30,00 | 2.259.360 USD | |
2022-11-04 | 2022-11-02 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
27.038
-2.6%
30,02811.681 USD |
27.038 -2.6% | 30,02 | 811.681 USD | |
2022-11-04 | 2022-11-02 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
96.581
-1.7%
30,022.899.362 USD |
96.581 -1.7% | 30,02 | 2.899.362 USD | |
2022-11-01 | 2022-11-01 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
1.044
-0.1%
31,0832.448 USD |
1.044 -0.1% | 31,08 | 32.448 USD | |
2022-11-01 | 2022-11-01 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
3.727
-0.1%
31,08115.835 USD |
3.727 -0.1% | 31,08 | 115.835 USD | |
2022-11-01 | 2022-11-01 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
15.804
-1.5%
30,57483.128 USD |
15.804 -1.5% | 30,57 | 483.128 USD | |
2022-11-01 | 2022-11-01 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
56.455
-1.0%
30,571.725.829 USD |
56.455 -1.0% | 30,57 | 1.725.829 USD | |
2022-11-01 | 2022-10-31 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
26.383
-2.4%
30,23797.558 USD |
26.383 -2.4% | 30,23 | 797.558 USD | |
2022-11-01 | 2022-10-31 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
94.239
-1.7%
30,232.848.845 USD |
94.239 -1.7% | 30,23 | 2.848.845 USD | |
2022-11-01 | 2022-10-28 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
19.915
-1.8%
30,00597.450 USD |
19.915 -1.8% | 30,00 | 597.450 USD | |
2022-11-01 | 2022-10-28 |
Kymera Therapeutics Inc
(KYMR)
|
GV Geplanter Verkauf |
71.135
-1.2%
30,002.134.050 USD |
71.135 -1.2% | 30,00 | 2.134.050 USD | |
2022-01-11 | 2022-01-11 |
Vigil Neuroscience Inc
(VIGL)
|
K Kauf |
535.000
+12.5%
14,007.490.000 USD |
535.000 +12.5% | 14,00 | 7.490.000 USD | |
2021-08-12 | 2021-08-11 |
Kymera Therapeutics Inc
(KYMR)
|
V Verkauf |
242.133
-100.0%
61,0014.770.113 USD |
242.133 -100.0% | 61,00 | 14.770.113 USD | |
2021-03-16 | 2021-03-12 |
Kymera Therapeutics Inc
(KYMR)
|
V Verkauf |
229.350
-100.0%
56,5012.958.275 USD |
229.350 -100.0% | 56,50 | 12.958.275 USD | |
2020-07-01 | 2020-06-29 |
Magenta Therapeutics Inc
(MGTA)
|
K Kauf |
1.250.000
+inf%
8,0010.000.000 USD |
1.250.000 +inf% | 8,00 | 10.000.000 USD | |
2019-07-23 | 2019-07-19 |
AVROBIO Inc
(AVRO)
|
K Kauf |
810.811
+17.0%
18,5015.000.004 USD |
810.811 +17.0% | 18,50 | 15.000.004 USD | |
2019-03-22 | 2019-03-20 |
Magenta Therapeutics Inc
(MGTA)
|
V Verkauf |
14.245
-100.0%
17,86254.416 USD |
14.245 -100.0% | 17,86 | 254.416 USD |